Investors House (INVEST) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Investors House stock €6.16, price €2.69, upside +129.0%, quality 54 out of 100. Rating: strongly undervalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range €2.07 – €4.60 · fair‑value band €2.82 – €11.15 · the €2.69 price screens below the €6.16 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.
Follow Investors House in your weekly email
Every Wednesday you see whether Investors House is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Investors House Oyj operates as a real estate investment company in Finland and Estonia. The company operates in two segments, Investments in Real Estate and Business Service. It owns, operates, leases, and manages university town and provincial center properties in 11 locations.
Show moreShow less
The company was formerly known as SSK Suomen Saastajien Kiinteistot Oyj and changed its name to Investors House Oyj in April 2015. Investors House Oyj was founded in 1988 and is based in Helsinki, Finland.
Stock analysis
Investors House (INVEST) currently trades at €2.69, while our model-based Fair Value estimate is €6.16, implying the stock looks roughly 56% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of €6.59 per share, and 13 of the 14 models we run sit above the €2.69 price.
Bear case: the Asset-Based group reads lowest at €1.74, and 1 of the 14 models stay below the price. Data coverage for this calculation is high.
Scenario range: €2.82 (bear) to €11.15 (bull), the price of €2.69 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Real Estate sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Investors House reported revenue of €8.4M in FY2025 versus €9.8M in FY2021, a compound −3.7%/yr. Reported net income was €4.3M in FY2025.
Key figures
Market cap €16.8M Micro · P/E ratio 20.7 · P/S ratio 2.71 · EPS (TTM) €0.1300 · Dividend yield 13.8% · Net margin 12.7% · Return on equity 2.8% · Return on assets (EBIT) 5.5% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 60 out of 100 (low confidence).
What moves the price
The share trades about 38% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −16% fair-value upside, at 129%, INVEST screens cheaper than that median.
Fair Value models
Bear€2.82Fair Value €6.16Bull€11.15
Price €2.69 · Upside +129.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.36/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−15.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.4%
Start year 2020 (pandemic). Over 10 years: +20.3% a year
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
≈ +35.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year≈ +21.6%
Dividend (yield on the price)13.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.base effect: 21.6% / −4.0%
Profit margin 2019 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.35% → 35%
⚠ Base effect: the rate starts in the earnings trough around 2020 (starting value 0.27 per share, median 1.10 in 2015 to 2018). It measures the recovery from the trough, not lasting growth.
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+11.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +9.5% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate Services · 472 stocks
Beats the industry median on 5/14 measures
Overall it trails its industry peers.
Valuation
Quality Score54 · Below median
Fair Value upside+129.0% · Top 25%
Profitability
Return on equity (12 months)2.8% · Below median
Return on assets10.7% · Top 25%
Net margin (12 months)12.7% · Below median
Operating margin (12 months)27.8% · Above median
Growth and dividend
Revenue growth (quarter YoY)−40.7% · Bottom 25%
Dividend yield (12 months)13.8% · Top 25%
Balance sheet
Debt / equity0.67× · Above median
Valuation Multiplesvs Real Estate Services median · lower = cheaper
P/E (12 months)20.7× · Priciest 25%
P/B0.82× · Pricier than median
P/S (12 months)2.71× · Cheaper than median
Price / free cash flow (fiscal year)16.2× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Investors House Fair Value". https://www.fairvalue-calculator.com/stock/INVEST
Frequently asked questions
Is Investors House (INVEST) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of €6.16 versus a price of €2.69, about +129% upside (undervalued).
What is the fair value of INVEST?
Our model-based fair value for Investors House is €6.16 (as of Nov 7, 2026), built from audited fundamentals. The current price: €2.69.
What is the quality score of INVEST?
Investors House has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Investors House (INVEST)?
Our model-based price target is the fair value of €6.16 (as of Nov 7, 2026) from 14 valuation models. Cautious scenario €2.82, optimistic scenario €11.15. It is a calculation from audited fundamentals, not an analyst target.
What is the Investors House stock forecast for 2026?
Our models put fair value at €6.16, about +129% upside versus a price of €2.69 (undervalued). Cautious scenario €2.82, optimistic scenario €11.15. The calculation is refreshed regularly with new filings.
What is the revenue of Investors House (INVEST)?
Investors House reported trailing-twelve-month revenue of about €6.2M (latest available figure, as of Nov 7, 2026).
Does Investors House pay a dividend?
Investors House currently shows a dividend yield of 13.75% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Investors House (INVEST) and when is the ex-dividend date?
Investors House pays a dividend of €0.37 per share a year, a dividend yield of 13.8%. The last ex-dividend date was Aug 18, 2026. A dividend has been paid every year since at least 2015. Free cash flow covers the dividend 0.45 times. Our assessment: Pays more than it earns. The company pays out more in dividends than it earns, and free cash flow clearly does not cover the dividend either. It may need to be cut unless profits recover.
What growth is priced into Investors House (INVEST)?
For today's price to be fair in a discounted-cash-flow model, Investors House would have to grow free cash flow by +11.9 % per year for five years (discount rate 9.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -2.4 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of INVEST use?
Our models discount Investors House at 9.0 %: a base by market capitalisation (nano), damped by beta 0.64, country premium for Finland. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Investors House that is +11.9 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.0 %) and the same formula as our fair value.
How much growth has Investors House (INVEST) delivered so far?
Over the past 5 years revenue at Investors House grew -2.4 % a year. The price currently implies free-cash-flow growth of +11.9 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Investors House (INVEST) growing?
The median revenue growth in the sector is +2.7 % a year. That is the yardstick for the growth priced into Investors House (+11.9 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Investors House (INVEST)?
The free-cash-flow yield on the price is 6.18 %: that much free cash flow Investors House produces per unit of market value. When it exceeds the discount rate of our models (9.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Investors House (INVEST)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Investors House it is €6.16 per share (as of Nov 7, 2026), against a price of €2.69. It is the blended result of 14 valuation models in 5 families (DCF Models, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Investors House stock overvalued or undervalued in 2026?
As of Nov 7, 2026, INVEST trades below its calculated fair value: price €2.69, fair value €6.16, a gap of about +129% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of INVEST?
No. The price is what the market pays today (€2.69); the fair value is what the company's own numbers justify (€6.16). For Investors House the two are €3.47 per share apart. That gap is exactly why we show both numbers side by side.
How much is Investors House worth?
The market values Investors House at about €16.8M (market capitalisation, as of Nov 7, 2026). Per share that is €2.69; our models calculate a fair value of €6.16 per share.
What do the bullish and bearish scenarios say about INVEST?
Our models span a range for Investors House: cautious scenario €2.82, base €6.16, optimistic €11.15 per share (as of Nov 7, 2026, price €2.69). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of INVEST?
Investors House trades at a price-to-earnings ratio of 20.7 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €6.16 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 4.0 (reported for FY2025: 3.7). Median P/E at fiscal year-end, 8 fiscal years (2016 to 2025), reported earnings, FY2025 ex one-offs: 7.6. Other multiples: P/B 0.8, P/S 2.7, EV/EBITDA 19.2.
How solid is the balance sheet of Investors House (INVEST)?
Balance-sheet figures for Investors House (as of Nov 7, 2026): return on equity 2.8%, debt of 0.67 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is INVEST from its 52-week high?
Investors House trades at €2.69, about 38% below its 52-week high of €4.32 and at the low of €2.69 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of €6.16 is for.
Which stocks are comparable to Investors House?
From the same area (Real Estate) we also value CBRE Group, Cellnex Telecom, S.A, KE Holdings, Swire Properties Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Investors House stock attractive at the current price?
The data as of Nov 7, 2026: price €2.69, calculated fair value €6.16 (+129%), Quality Score 54/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of INVEST calculated?
We run Investors House through 14 models from 5 families: DCF Models, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of €6.16 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Investors House currently trades 56% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Investors House (INVEST)?
The closing price on Nov 6, 2026 was €2.69. Our model-based fair value is €6.16, about +129% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Investors House right now?
The price is below even our cautious bear case (€2.82). The market is more pessimistic than our downside scenario. The model range is unusually wide (€2.82 to €11.15). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Where does the earnings growth of Investors House (INVEST) come from?
Earnings per share at Investors House grew −3.8 % a year from 2015 to 2025. Broken into its drivers: revenue per share +8.5 %, EBIT margin −13.1 %, tax rate +0.7 %, residual (interest, one-offs) +1.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Investors House
How large is the market capitalisation of Investors House (INVEST)?
The market capitalisation of Investors House is €16.8M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Investors House (INVEST)?
The price-to-sales ratio of Investors House is 2.71 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Investors House (INVEST)?
Earnings per share at Investors House are €0.1300 (price ÷ EPS = P/E 20.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Investors House (INVEST)?
The dividend yield of Investors House is 13.8%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Investors House (INVEST)?
The net margin of Investors House is 12.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Investors House (INVEST)?
The return on equity (ROE) of Investors House is 2.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Investors House (INVEST)?
On an EBIT basis the return on assets of Investors House is 5.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Investors House (INVEST)?
The operating margin of Investors House is 27.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Investors House (INVEST)?
Revenue at Investors House is growing −40.7% versus a year earlier (3y avg +3.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Investors House (INVEST)?
Earnings per share at Investors House are growing −92.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Investors House (INVEST) carry?
The net debt of Investors House is €9.6M (fiscal year 2025, ≈ 9.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Investors House in the live analysis
One click puts Investors House on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 7, 2026